US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Antibody Technologies Market Research Reports & Industry Analysis

RSS Feeds

Antibody Technologies Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  
Antibodies in Oncology: Drug Pathway Analyzer 2015
1/12/2015 | published by: BioSeeker Group AB
... than 126 different tumor types. The rational for this plethora of treatment strategies is based on our increasing understanding of the 283 drug targets that are included in this drug-pathway analyzing tool. No less than ...  |  read more...
USD 6,746
Impact of Biosensing Technologies (Technical Insights)
12/26/2014 | published by: Frost & Sullivan
... element being analyzed, primarily biological element comprising of enzymes, antibodies, microbes, proteins, etc. and the transducer type being used for analyzing such as electrochemical, optical, calorimetric, etc. Biosensors is a multidisciplinary field and is based ...  |  read more...
USD 6,500
Advances in Biosensing Technologies (Technical Insights)
12/26/2014 | published by: Frost & Sullivan
... are profiled are in clinical applications such as in long-term implantable, short-term invasive, single shot and multi-analyses. Insights are provided in the report as to collaborations, demand side needs, recent developments and technology roadmap. The ...  |  read more...
USD 6,500
Antibodies in Oncology Drug Pipeline Update 2015
1/5/2015 | published by: BioSeeker Group AB
... of therapeutic antibodies. There are today 354 companies plus partners developing 707 antibody drugs in 1875 developmental projects in cancer. In addition, there are 6 suspended drugs and the accumulated number of ceased drugs over ...  |  read more...
USD 6,746
Antibody Drugs: Technologies and Global Markets
1/1/2015 | published by: BCC Research
... between 2014 and 2019 resulting in totals nearly $68.9 billion in 2014 and $122.6 billion globally in 2019. This report provides: An overview of the global market for therapeutic monoclonal antibody (mAb) drugs and related ...  |  read more...
USD 6,650
Antibody Partnering Terms and Agreements
1/1/2015 | published by: Current Partnering
... report provides a detailed understanding and analysis of how and why companies enter antibody partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right ...  |  read more...
USD 2,995
Emerging Trends in Cell Banking (Technical Insights)
12/29/2014 | published by: Frost & Sullivan
... and comparison with other drugs, or the detection of antidrug antibodies (ADAs) or neutralizing antibodies (NAB), represent critical stages in drug discovery and development. On that note, cells and cell-based reagents constitute the foundations of ...  |  read more...
USD 6,500
Single Use Bioreactor Market by Product Type (Recombinant Proteins, Monoclonal Antibodies), Cell Type (Bacteria, Yeast), Technology (Stirred SUB, Single Use Bubble Column Bioreactor), End User(Bio pharmaceutical Manufacturers) - Global Forecast to 2019
11/3/2014 | published by: MarketsandMarkets
... such as China and India are lucrative markets for single-use bioreactors (SUB), owing to the low cost benefits offered by these nations. The report segments the global SUB market by molecule type, type of cell, ...  |  read more...
USD 4,650
Anti-CD22 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD22 Antibody. This report provides information on the therapeutic development based on the Anti-CD22 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD25 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD25 Antibody. This report provides information on the therapeutic development based on the Anti-CD25 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD274 (PD-L1) Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... the understanding for all the pipeline drugs that fall under Anti-CD274 (PD-L1) Antibody. This report provides information on the therapeutic development based on the Anti-CD274 (PD-L1) Antibody dealing with mechanism of action, comparative analysis at ...  |  read more...
USD 1,250
Anti-CD279 (PD-1) Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... the understanding for all the pipeline drugs that fall under Anti-CD279 (PD-1) Antibody. This report provides information on the therapeutic development based on the Anti-CD279 (PD-1) Antibody dealing with mechanism of action, comparative analysis at ...  |  read more...
USD 1,250
Anti-CD3 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD3 Antibody. This report provides information on the therapeutic development based on the Anti-CD3 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD38 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD38 Antibody. This report provides information on the therapeutic development based on the Anti-CD38 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD4 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD4 Antibody. This report provides information on the therapeutic development based on the Anti-CD4 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD40 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD40 Antibody. This report provides information on the therapeutic development based on the Anti-CD40 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD52 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD52 Antibody. This report provides information on the therapeutic development based on the Anti-CD52 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD6 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD6 Antibody. This report provides information on the therapeutic development based on the Anti-CD6 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD80 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD80 Antibody. This report provides information on the therapeutic development based on the Anti-CD80 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD95 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD95 Antibody. This report provides information on the therapeutic development based on the Anti-CD95 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CS1 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CS1 Antibody. This report provides information on the therapeutic development based on the Anti-CS1 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-Dickkopf-1 (Dkk-1) Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... the understanding for all the pipeline drugs that fall under Anti-Dickkopf-1 (Dkk-1) Antibody. This report provides information on the therapeutic development based on the Anti-Dickkopf-1 (Dkk-1) Antibody dealing with mechanism of action, comparative analysis at ...  |  read more...
USD 1,250
Anti-CD19 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD19 Antibody. This report provides information on the therapeutic development based on the Anti-CD19 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD28 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD28 Antibody. This report provides information on the therapeutic development based on the Anti-CD28 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
Anti-CD30 Antibody -Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... for all the pipeline drugs that fall under Anti-CD30 Antibody. This report provides information on the therapeutic development based on the Anti-CD30 Antibody dealing with mechanism of action, comparative analysis at various stages covering Filed, ...  |  read more...
USD 1,250
< prev 1    3  4  5  6  7  8  9